Tags

Type your tag names separated by a space and hit enter

European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Int J Fertil Menopausal Stud. 1995; 40 Suppl 2:73-9.IJ

Abstract

The European Society of Contraception developed a survey to examine birth control methods in the 12 countries++ of the European Community. Responses to those questions relating to prescribing++ practices of oral contraceptives (OCs) are presented herein. The survey was sent to 400 physicians. One hundred two responded, most from France, Belgium, and the United Kingdom. The responses revealed that the most popular OCs are modern combined formulations containing low doses of ethinyl estradiol and progestogens such as norgestimate, desogestrel, gestodene, and levonorgestrel. More than half of physicians prescribe a particular formulation because of its tolerability and 20% because of its hormonal content. More than 90% prescribe OCs to healthy, nonsmoking women over 40. However, three fourths will not prescribe OCs to smokers over 35. Half of physicians recommend mammography for their older OC patients. Half also recommend cholesterol screening, but 8% only for women over 30. Most physicians are no longer reluctant to prescribe OCs to their diabetic patients: 61% prescribe OCs for women with non-insulin-dependent diabetes, 56% for those with insulin-dependent diabetes, and 85% for those with a history of gestational diabetes. Despite recent studies showing no relation between past OC use and cardiovascular disease, 42% of physicians said that their greatest OC-related health concern is cardiovascular disease. One third cited noncompliance as their greatest concern. These results reveal inhomogeneous prescribing practices for OCs among European physicians. ¿Over-screening¿--not prescribing the pill because of perceived (but not necessarily real) health risks--may be depriving many women of the contraceptive and noncontraceptive benefits of OCs. Complete and accurate information--as promoted by the European Society of Contraception--is one way to combat such overscreening.

Authors+Show Affiliations

Serfaty D
Centre de Régulation des Naissances, Hôpital Saint-Louis, Paris, France.
Wildemeersch D
No affiliation info available
Verougstraete A
No affiliation info available
Creatsas G
No affiliation info available

MeSH

AdultAgingCardiovascular DiseasesContraceptionContraceptives, OralData CollectionDesogestrelDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Estradiol CongenersEthinyl EstradiolEuropeFemaleHumansLevonorgestrelNorgestrelNorpregnenesProgesteroneProgesterone CongenersRisk FactorsSmokingSurveys and Questionnaires

Pub Type(s)

Journal Article

Language

eng

PubMed ID

8574253

Citation

Serfaty, D, et al. "European Society of Contraception Oral Contraceptives Survey Update: Birth Control Methods in "Europe of the 12"." International Journal of Fertility and Menopausal Studies, vol. 40 Suppl 2, 1995, pp. 73-9.
Serfaty D, Wildemeersch D, Verougstraete A, et al. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12". Int J Fertil Menopausal Stud. 1995;40 Suppl 2:73-9.
Serfaty, D., Wildemeersch, D., Verougstraete, A., & Creatsas, G. (1995). European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12". International Journal of Fertility and Menopausal Studies, 40 Suppl 2, 73-9.
Serfaty D, et al. European Society of Contraception Oral Contraceptives Survey Update: Birth Control Methods in "Europe of the 12". Int J Fertil Menopausal Stud. 1995;40 Suppl 2:73-9. PubMed PMID: 8574253.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12". AU - Serfaty,D, AU - Wildemeersch,D, AU - Verougstraete,A, AU - Creatsas,G, PY - 1995/1/1/pubmed PY - 1995/1/1/medline PY - 1995/1/1/entrez KW - Contraception KW - Contraceptive Methods KW - Delivery Of Health Care KW - Developed Countries KW - Distributional Activities KW - Europe KW - Family Planning KW - Health KW - Health Personnel KW - Oral Contraceptives KW - Organization And Administration KW - Physicians KW - Prescriptions KW - Program Activities KW - Programs KW - Research Methodology KW - Research Report KW - Sampling Studies KW - Studies KW - Surveys SP - 73 EP - 9 JF - International journal of fertility and menopausal studies JO - Int J Fertil Menopausal Stud VL - 40 Suppl 2 N2 - The European Society of Contraception developed a survey to examine birth control methods in the 12 countries++ of the European Community. Responses to those questions relating to prescribing++ practices of oral contraceptives (OCs) are presented herein. The survey was sent to 400 physicians. One hundred two responded, most from France, Belgium, and the United Kingdom. The responses revealed that the most popular OCs are modern combined formulations containing low doses of ethinyl estradiol and progestogens such as norgestimate, desogestrel, gestodene, and levonorgestrel. More than half of physicians prescribe a particular formulation because of its tolerability and 20% because of its hormonal content. More than 90% prescribe OCs to healthy, nonsmoking women over 40. However, three fourths will not prescribe OCs to smokers over 35. Half of physicians recommend mammography for their older OC patients. Half also recommend cholesterol screening, but 8% only for women over 30. Most physicians are no longer reluctant to prescribe OCs to their diabetic patients: 61% prescribe OCs for women with non-insulin-dependent diabetes, 56% for those with insulin-dependent diabetes, and 85% for those with a history of gestational diabetes. Despite recent studies showing no relation between past OC use and cardiovascular disease, 42% of physicians said that their greatest OC-related health concern is cardiovascular disease. One third cited noncompliance as their greatest concern. These results reveal inhomogeneous prescribing practices for OCs among European physicians. ¿Over-screening¿--not prescribing the pill because of perceived (but not necessarily real) health risks--may be depriving many women of the contraceptive and noncontraceptive benefits of OCs. Complete and accurate information--as promoted by the European Society of Contraception--is one way to combat such overscreening. SN - 1069-3130 UR - https://www.unboundmedicine.com/medline/citation/8574253/European_Society_of_Contraception_oral_contraceptives_survey_update:_birth_control_methods_in_"Europe_of_the_12"_ L2 - https://medlineplus.gov/birthcontrol.html DB - PRIME DP - Unbound Medicine ER -